Pharmacological properties of thalidomide and its analogues.
De Sanctis
Juan B
JB
Instituto de Inmunología, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela. juan.desanctis@ucv.ve
Mijares
Michael
M
Suárez
Alírica
A
Compagnone
Reinaldo
R
Garmendia
Jenny
J
Moreno
Dolores
D
Salazar-Bookaman
Margarita
M
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D000077269:Lenalidomide; D010330:Patents as Topic; D013792:Thalidomide / Q000031:analogs & derivatives / Q000494:pharmacology*
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D013792:Thalidomide; C467566:pomalidomide; D000077269:Lenalidomide